West Virginia’s attorney general sued 14 out-of-state drug distributors, including Cardinal Health, AmerisourceBergen, and The Harvard Drug Group, alleging the companies distribute pain medications, such as oxycodone, to pharmacies and doctors who prescribe and dispense them for non-legitimate medical purposes. The state sought to enjoin the companies from distributing any controlled substance for non-medical purposes, recover damages, and force the companies to promptly inform state authorities of all suspicious orders for controlled substances from West Virginia. In December 2016, it was reported that Cardinal Health and AmerisourceBergen settled the lawsuit: Cardinal Health agreed to pay the state $20 million, and AmerisourceBergen agreed to pay $16 million. Both companies denied any fault or liability. The Harvard Drug Group previously settled for $1 million.